Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study

BACKGROUND: Glatiramer acetate (GA) and interferon-beta (INFb) are first-line disease modifying drugs for relapsing remitting multiple sclerosis (RRMS). Treatment with INFb is associated with a significant increase in health-related quality of life (HR-QoL) in the first 12 months. It is not known wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Jongen, Peter J, Lehnick, Dirk, Sanders, Evert, Seeldrayers, Pierette, Fredrikson, Sten, Andersson, Magnus, Speck, Joachim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999586/
https://www.ncbi.nlm.nih.gov/pubmed/21078142
http://dx.doi.org/10.1186/1477-7525-8-133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999586/
https://www.ncbi.nlm.nih.gov/pubmed/21078142
http://dx.doi.org/10.1186/1477-7525-8-133

Ejemplares similares